Advertisement

Updated December 18th, 2020 at 12:08 IST

'Black' fungal disease that causes blindness infects 44 in Ahmedabad, 9 killed

Just as the news of COVID-19 vaccines left millions across the nation exhilarated, doctors have now flagged a rare but deadly fungal disease, Mucormycosis.

Reported by: Aanchal Nigam
Fungal Disease
| Image:self
Advertisement

Just as the news of COVID-19 vaccines left millions across the nation exhilarated, doctors have now flagged a rare but reportedly deadly fungal disease, Mucormycosis or Black Fungus, with cases being recorded in Delhi, Mumbai, and Ahemdabad. As per media reports, out of the total 44 cases of Mucormycosis detected in Ahemdabad, at least nine patients have died with infections resulting in blindness for some people.

As per reports, the fungal infection was only seen rarely before the COVID-19 pandemic impacted the nation but is now being linked to the complications among the patients who recovered from the novel coronavirus infection. 

Just in the last 15 days, the ENT surgeons at Sir Ganga Ram Hospital (SGRH) witnessed 13 cases of the ‘COVID-19-triggered’ fungal infection. Calling it an “alarming affliction”, they said, “although rare, is not new. What is new is COVID-19 triggering mucormycosis” that can also lead to loss of sight and removal of nose and jaw bone.

The SGRH said in a statement, “In the last 15 days, ENT surgeons have seen 13 cases of COVID-19-triggered mucormycosis in over 50 per cent patients, with loss of eyesight, and removal of nose and jaw bone needed.”

Read - Puducherry Adds 50 New COVID-19 Cases, 1 Death Pushes Toll To 623

Read - COVID-19 Vaccine Induces Broad Antibody, T Cell Functions With Two-dose Regimen: Oxford

Mucormycosis: ‘Serious but rare’ fungal infection

The Black Fungus or mucormycosis that has been the new worry for the medical professionals in some cities, has also been the cause of death in transplants, and intensive care units (ICU) and immunodeficient people even in the past. But recently, the rare disease has recorded an uptick among the recovering COVID-19 patients. 

According to the US Centers for Disease Control and Prevention (CDC), Mucormycosis is “serious but rare” and is caused by a group of molds called mucormycetes. Mostly, the disease affects the people who have prior health problems or take medicines that lower the body’s ability to tackle germs and illness and is caused mainly by inhaling fungal spores from the air.

Read - COVID-19 Triggering Rare, Deadly Fungal Infection, Claims Ganga Ram Hospital

Read - Dr VK Paul Reacts To Fungal Infection Cases Reported In Delhi: 'Can Take A Serious Turn'

Symptoms:

The symptoms of mucormycosis depend on where in the body the fungus is growing, it can primarily impact any part.

If the fungus grows in sinus and brain -

  • One-sided facial swelling
  • Headache
  • Nasal or sinus congestion
  • Black lesions on nasal bridge or upper inside of mouth that quickly become more severe
  • Fever

Pulmonary (lung) mucormycosis include -

  • Fever
  • Cough
  • Chest pain
  • Shortness of breath

Moreover, Cutaneous (skin) mucormycosis can lead to blisters or ulcers and the infected area can turn black. Other symptoms also include pain, warmth, excessive redness, or swelling around a wound. If the pathogen ends up in gastrointestinal part, it leads to Abdominal pain, Nausea and vomiting, Gastrointestinal bleeding.

How is mucormycosis treated?

As per US CDC, “Mucormycosis is a serious infection and needs to be treated with prescription antifungal medicine, usually amphotericin B, posaconazole, or isavuconazole...Often, mucormycosis requires surgery to cut away the infected tissue.”

Read - 29 New COVID-19 Cases Push Arunachal Pradesh's Tally To 16,603

Read - COVID-19 Tally In India Rises To 99.79 Lakh

Advertisement

Published December 18th, 2020 at 12:10 IST

Your Voice. Now Direct.

Send us your views, we’ll publish them. This section is moderated.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Whatsapp logo